HAP Trading’s Briacell Therapeutics BCTX Stock Holding History

HAP Trading’s Portfolio BCTX Stock Details BCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-314	Closed	-$12K	–	1524
2022 Q3	$12K	Buy	314 +201	+178%	+$202K	﹤0.01%	1273
2022 Q2	$4K	Buy	113 +6	+6%	+$5.93K	﹤0.01%	1648
2022 Q1	$19K	Sell	107 -72	-40%	-$85.2K	﹤0.01%	1583
2021 Q4	$16K	Buy	+179	New	+$235K	﹤0.01%	1893

Other funds holding BCTX

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

K.J. Harrison & Partners Toronto, Ontario, Canada $608M AUM 45.31% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return

Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return

Simplex Trading

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Concord Wealth Partners Abingdon, Virginia $873M AUM 24.02% 1-Year Est. Return

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return